VALBIOTIS Announces Positive Results From the Phase IIA Clinical Study of VALEDIA®, Now the First Product Proven Effective in People With PrediabetesAllbiopro2019-07-04T09:36:28+09:007월 4th, 2019|
Puma Biotechnology Presents Interim Results from the Biliary Tract Cohort of its Phase II SUMMIT Basket Trial of Neratinib at the ESMO World Congress on Gastrointestinal Cancer 2019Allbiopro2019-07-04T09:35:31+09:007월 4th, 2019|
First time human-on-a-chip predicts in vivo results based on in vitro modelAllbiopro2019-07-04T09:34:34+09:007월 4th, 2019|
ADVENT ACCESS Receives CE Mark Certificate for Pioneering av-GuardianTM Vascular Access SystemAllbiopro2019-07-04T09:33:40+09:007월 4th, 2019|
Path-to-Market: How Regulatory Technology Can Help Companies Expand to AsiaAllbiopro2019-07-04T09:32:46+09:007월 4th, 2019|
Unum Plunges After FDA Places Another Clinical Hold on Company AssetAllbiopro2019-07-04T09:31:53+09:007월 4th, 2019|
Genentech’s Xofluza Comparable to Tamiflu in Phase III TrialAllbiopro2019-07-04T09:31:00+09:007월 4th, 2019|
Sen. Warren on Former FDA Commissioner’s Pfizer Appointment: “Smacks of Corruption”Allbiopro2019-07-04T09:30:07+09:007월 4th, 2019|
Research Roundup: Gut Bacteria to Prevent and Reverse Food Allergies and MoreAllbiopro2019-07-04T09:28:22+09:007월 4th, 2019|
Social Media Sites Cracking Down on Misleading Medical ClaimsAllbiopro2019-07-04T09:26:25+09:007월 4th, 2019|
Elimination of HIV from Genome Could Potentially Lead to CureAllbiopro2019-07-04T09:24:30+09:007월 4th, 2019|
States Pause Lawsuits Against Insys During Bankruptcy ProceedingsAllbiopro2019-07-04T09:23:32+09:007월 4th, 2019|
Confo Therapeutics and DyNAbind Announce Drug Discovery Collaboration to Identify Novel GPCR-Modulating CompoundsAllbiopro2019-07-04T09:22:35+09:007월 4th, 2019|
Novartis struggling to win payer coverage for $2.1M gene therapy Zolgensma: analystsAllbiopro2019-07-04T09:21:35+09:007월 4th, 2019|
Post-Shire buy, Takeda investors want executives to return pay if performance lagsAllbiopro2019-07-04T09:20:37+09:007월 4th, 2019|
